Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Sales (2024 - 2025)

Kura Oncology (KURA) has disclosed Return on Sales for 2 consecutive years, with 4.67% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 4735.0% to 4.67% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.13% through Dec 2025, down 11035.0% year-over-year, with the annual reading at 4.13% for FY2025, 90.0% down from the prior year.
  • Return on Sales for Q4 2025 was 4.67% at Kura Oncology, down from 3.57% in the prior quarter.
  • The five-year high for Return on Sales was 132.05% in Q3 2024, with the low at 4.67% in Q4 2025.